These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2594825)

  • 21. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
    Lu B; Wen R; Yang H; He Y
    Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained-release dosage form of phenylpropanolamine hydrochloride (3). Application of factorial design.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(4):439-44. PubMed ID: 7931943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of press-coated tablets with controlled-release effect with a base of poly-d(-)-3-hydroxybutyric acid].
    Korsatko-Wabnegg B
    Pharmazie; 1990 Nov; 45(11):842-4. PubMed ID: 2100336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Injection molding of preoral sustained-release preparations. 5. Development of a solid foam body].
    Schmeiss U; Hüttenrauch R
    Pharmazie; 1976 Aug; 31(8):559-62. PubMed ID: 996077
    [No Abstract]   [Full Text] [Related]  

  • 31. Sustained release isoniazid tablets. I--Formulation and in vitro evaluation.
    Bulut-Oner F; Capan Y; Kas S; Oner L; Hincal AA
    Farmaco; 1989; 44(7-8):739-52. PubMed ID: 2590371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scleroglucan sustained release oral preparations. Part II. Effects of additives.
    Alhaique F; Beltrami E; Riccieri FM; Santucci E; Touitou E
    Drug Des Deliv; 1990 Mar; 5(3):249-57. PubMed ID: 1670505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Galenical possibilities and problems in protraction of drug effects (author's transl)].
    Müller F
    Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ cross-linked matrix tablets for sustained salbutamol sulfate release - formulation development by statistical optimization.
    Malakar J; Das K; Nayak AK
    Polim Med; 2014; 44(4):221-30. PubMed ID: 25932903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of compression pressure, drug particle size, drug form and test medium on the release of active ingredients from matrix tablets of a silicon base].
    Moldenhauer H; Kala H; Erbe S
    Pharmazie; 1975 Dec; 30(12):783-7. PubMed ID: 1219796
    [No Abstract]   [Full Text] [Related]  

  • 36. Application of a Biodegradable Polyesteramide Derived from L-Alanine as Novel Excipient for Controlled Release Matrix Tablets.
    Bonillo Martínez AD; Galán ICR; Bellver MVM
    AAPS PharmSciTech; 2017 Nov; 18(8):3286-3295. PubMed ID: 28589306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression.
    Saurí J; Millán D; Suñé-Negre JM; Pérez-Lozano P; Sarrate R; Fàbregas A; Carrillo C; Miñarro M; Ticó JR; García-Montoya E
    Int J Pharm; 2014 Jan; 461(1-2):38-45. PubMed ID: 24284019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosin: a naturally derived excipient in drug delivery systems.
    Kumar S; Gupta SK
    Polim Med; 2013; 43(1):45-8. PubMed ID: 23808195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Injection-molding technic for the production of oral delayed-action preparations. 3. Addition of highly water-soluble substances].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1975 Aug; 30(8):536-40. PubMed ID: 1178778
    [No Abstract]   [Full Text] [Related]  

  • 40. SeDeM Expert System, an Innovative Tool for Developing Directly Compressible Tablets: A Review.
    Singh I; Thakur AK; Bala R; Madan R
    Curr Drug Res Rev; 2021; 13(1):16-24. PubMed ID: 32988362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.